Rate of hepatitis C reinfection after successful direct-acting antivirals treatment among people who inject drugs in Spain: the LIVERate study

Rate of hepatitis C reinfection after successful direct-acting antivirals treatment among people who inject drugs in Spain: the LIVERate study

Abstract Background Hepatitis C virus (HCV) reinfection following successful treatment threatens the achievement of HCV elimination. The primary aim of this study is to assess reinfection rate three years after sustained virologic response (SVR) in people who inject drugs (PWID) that are on opioid a...

Full description

Saved in:
Bibliographic Details
Main Authors: Fernando Chacón, Luis Morano, Jordi Navarro, Rafael Granados, Josep Mª Llibre, Pablo Ryan, Teresa Aldámiz-Echevarria, Luz Martín Carbonero, Marc Puigvehí, Imma Clotet-Codina, Nuria Sanchez-Vega, Enrique Vacas, Oscar Rincón, Juan Berenguer, Javier Crespo, Carlos Roncero
Format: Article
Language:English
Published: BMC 2024-11-01
Series:BMC Public Health
Subjects:
Hepatitis C
Reinfection
People who inject drugs
Opioid substitute therapy
Risk behaviors
Direct-acting antivirals
Online Access:https://doi.org/10.1186/s12889-024-20625-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12889-024-20625-3

Similar Items